Stay updated with breaking news from Phoremost Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionLONDON, May 22, 2024 /PRNewswire/ -- NeoPhore
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics PhoreMost Ltd., a leading UK biopharmaceutical company unlocking
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
PhoreMost Ltd. announced Professor Peter Parker and Dr Jason Imbriglio as members of its Scientific Advisory Board (SAB).